Genio for healthcare professionals
The Genio system is the world’s first and unique battery-free, leadless, 1.5T and 3T full-body MRI compatible and single incision neurostimulator for patients who suffer from moderate to severe Obstructive Sleep Apnea (OSA). By dissociating the neurostimulator from its power unit and thanks to the unique bilateral nerve stimulation, the Genio sleep apnea treatment will shift the current paradigm in OSA therapy.
Patient outcomes
With the help of Genio hundreds of patients improved their lives
%
of patients reported using Genio more than 5 days/week
%
decrease of bed partners reporting loud or very intense snoring
%
of patients are satisfied with the Genio system
BLAST OSA Study
The BLAST OSA study data, published in the European Respiratory Journal, provide compelling safety and efficacy data of the Genio system, demonstrating that treatment with the Genio system resulted in a significant improvement in sleep apnea symptoms and patients' quality of life.
Clinical Research Program
Nyxoah is conducting several studies in Australia, New Zealand, Europe and USA, which are showing promising results so far.
Surgical implantation procedure
The implantation procedure is performed by a trained and certified surgeon. The procedure requires only one incision, takes about one hour to complete and is done under general anesthesia. The Implantable Stimulator constitutes the only implanted component of the Genio system. The device is placed over the genioglossus muscle, close to the tongue’s hypoglossal nerve.
Genio reinvents sleep
Genio is the world’s first and unique battery-free, leadless and single incision neurostimulator that was designed and developed with the user in mind.
Indications
Genio is indicated for moderate to severe OSA patients (AHI of 15 to 65) who are not significantly overweight, and who cannot tolerate, have failed or refused Positive Airway Pressure (PAP) therapy.
Surgeon Certification Process
To get started with Genio you need to follow a certain certification process: